Billionaire Profile
Yves-Loic Martin
Global Rank
#2452

Image: Martin Lee from London, UK | CC BY-SA 4.0 | via Wikimedia Commons

Yves-Loic Martin

CEO, Laboratory services
FRANCE
Real-Time Net Worth
$1.556B
Estimated based on Laboratory services stock value as of March 6, 2026
-1.66% (24h)
Age
60
Source
Laboratory services
Industry
Healthcare
Citizenship
FRANCE

Biography

Yves-Loic Martin, a prominent figure in the laboratory services industry, is estimated to have a net worth of $1.6 billion as of February 2024. He is the former Chief Technology Officer (CTO) of Eurofins Scientific, a global leader in testing for the food, pharmaceutical, and environmental sectors. His career, marked by his tenure at Eurofins since 1992, has been instrumental in the company's growth, and he owns approximately 10% of the company. Martin's achievements include leading technological innovation within Eurofins and contributing significantly to its expansion into a worldwide enterprise with over 900 laboratories across the globe. While no specific philanthropic activities are readily available, his ongoing role on Eurofins' board demonstrates his continued influence and commitment to the company's strategic direction.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Yves-Loic Martin, a French citizen residing in Nantes, France, was born into a family of academics. He earned an undergraduate degree from École Polytechnique and later pursued graduate studies at the Université de Paris IV Paris-Sorbonne, culminating in a doctorate from Institut National Agronomique Paris-Grignon.

Rise to Success

Martin's career is closely tied to Eurofins Scientific, a laboratory services company founded by his brother, Gilles Martin. He joined Eurofins in 1992 and quickly advanced, becoming the Chief Technology Officer (CTO) in 1998. Under his leadership, Eurofins went public in 1997, which fueled the company’s expansion. He stepped down as CTO in 2015, but he remains a board member.

Key Business Strategies

During his time as CTO, Martin focused on expanding Eurofins' global presence. His strategic vision helped grow the company into a major player in the testing industry, with a substantial presence in food, pharmaceutical, and environmental testing.

Philanthropy

Specific philanthropic details are unavailable in the search results. However, his continued involvement as a board member at Eurofins suggests a dedication to the company's ongoing success and strategic direction.

Career Milestones

1992

Joined Eurofins

Began career at Eurofins Scientific.

1998

Chief Technology Officer

Became CTO of Eurofins, driving technological innovation and expansion.

1997

Eurofins went public

Played a crucial role in the company's expansion by going public.

2015

Stepped down as CTO

Stepped down as CTO but remained on the board, maintaining influence.

Controversies & Challenges

2019

Rental Payments

Eurofins faced scrutiny for paying millions in rent to affiliates of Analytical Bioventures, an investment company owned by CEO Gilles Martin, his former wife, and Yves-Loic Martin.